Next Article in Journal
Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors
Next Article in Special Issue
Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection
Previous Article in Journal
Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019–20 Influenza Season—A Retrospective Cohort Analysis
Previous Article in Special Issue
Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants
 
 
Review

Article Versions Notes

Vaccines 2021, 9(10), 1147; https://doi.org/10.3390/vaccines9101147
Action Date Notes Link
article pdf uploaded. 8 October 2021 14:56 CEST Version of Record https://www.mdpi.com/2076-393X/9/10/1147/pdf-vor
article xml uploaded. 14 October 2021 11:08 CEST Original file https://www.mdpi.com/2076-393X/9/10/1147/xml
article pdf uploaded. 14 October 2021 11:08 CEST Updated version of record https://www.mdpi.com/2076-393X/9/10/1147/pdf
article supplementary file uploaded. 14 October 2021 11:08 CEST - https://www.mdpi.com/2076-393X/9/10/1147#supplementary
article html file updated 14 October 2021 11:09 CEST Original file -
article html file updated 30 July 2022 09:48 CEST Update https://www.mdpi.com/2076-393X/9/10/1147/html
Back to TopTop